Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 5, 2026Cancer Research

Validation And Projection Of Multi-Cancer Risk With Polygenic Scores And Non-Genetic Factors

View Full Paper
Ask AI
Bookmark
Share

Key result

Multi-cancer risk models combining non-genetic and polygenic factors identify ~24% of adults as high risk.

Why the study?

Risk assessment remains largely site-specific despite shared cancer risk factors, and multi-cancer risk prediction could provide a more holistic understanding to improve risk-stratified prevention.

Does a multi-cancer risk prediction model incorporating polygenic risk scores and non-genetic factors accurately stratify cancer risk in a non-Hispanic White population?

Population

Non-Hispanic White population in the PLCO Cancer Screening Trial and a US reference population

Design

Risk model development, prospective validation, and population projection study

Follow-up

10-yr

Authors

ENEmily L. NortonJohns Hopkins UniversityTAThomas AhearnNational Cancer InstituteSMSrijon MukhopadhyayUniversity of North Carolina at Chapel Hill

Discussion

Loading...

Member takes

Implication

May support risk-stratified screening in non-Hispanic White adults; extends prior models by integrating PRS with non-genetic factors.

Key Points

  • The aim is to validate and project multi-cancer risk using polygenic risk scores and non-genetic factors.
  • Developed absolute risk models for 14 cancer sites utilizing 26 risk factors and polygenic risk scores.
  • Used the iCARE tool to integrate risk parameters, population incidence rates, and mortality rates.
  • Evaluated model calibration and discrimination in the PLCO Cancer Screening Trial.
  • Projected multi-cancer risk for the US population via age-specific data from national surveys.
  • Validation indicated better calibration for females with an E/O risk of 1.05, while males had an E/O risk of 0.76.
  • Observed 10-year risk ranged from 3-20% in females and 7-30% in males across risk deciles.
  • 24% of males and 23% of females aged 18-74 identified as moderate to high risk (≥10% absolute risk).

Structured PICO

Does a multi-cancer risk prediction model incorporating polygenic risk scores and non-genetic factors accurately stratify cancer risk in a non-Hispanic White population?

P
Population
Non-Hispanic White population in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial, and a US reference population derived from NHANES, NHIS, and the Breast Cancer Surveillance Consortium.
I
Intervention
Multi-cancer risk prediction models (iCARE tool) incorporating 26 non-genetic risk factors and polygenic risk scores for 14 cancer sites.
O
Outcome
Calibration (expected/observed risk) and discrimination (area under the curve [AUC]) of site-specific and combined multi-cancer risk predictions.surrogate

A multi-cancer risk prediction model combining non-genetic factors and polygenic risk scores provides meaningful risk stratification, identifying nearly a quarter of US adults as having moderate to high 10-year cancer risk.

Limitations

  • Lack of validation in US non-White populations
  • Further model development and evaluation needed to ensure optimal performance across population groups

Cite This Study

Norton et al. (2026) studied this question. Multi-cancer risk models combining non-genetic factors and polygenic risk scores achieved 10-year risk AUCs of 0.60 in females and 0.61 in males, identifying ~24% of US adults as high risk.

synapsesocial.com/papers/69d1fe07a79560c99a0a488dhttps://doi.org/10.1158/1538-7445.am2026-3586
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Abstract 5087: Projecting individualized probabilities of lifetime total cancer risk across a population2026
  2. 2Abstract 3584: Characterizing polygenic risk scores for cancer in prospective cohorts: Considering PRS method construction, age of diagnosis, genetic ancestry, and sample overlap.2026
  3. 3Development and validation of an integrative 54 biomarker-based risk identification model for multi-cancer in 42,666 individuals: a population-based prospective study to guide advanced screening strategies2025 · 5 citations
  4. 4Abstract 4801: Clinical polygenic model to stratify risk of any, metastatic, and fatal prostate cancer in a randomized controlled trial of precision screening2024
  5. 5Development of a Breast Cancer Risk Prediction Model Integrating Monogenic, Polygenic, and Epidemiologic Risk2024 · 10 citations